Jak Knowles is the founder of Affini-T Therapeutics. Affini-T Therapeutics has raised $175M in total funding. Latest round: Seed.
Jak Knowles is a co-founder, President, and CEO of Affini-T Therapeutics, a Fred Hutchinson Cancer Research Center spinout. He previously co-founded Juno Therapeutics and collaborated with Fred Hutch colleagues to launch Affini-T to target oncogenic drivers like KRAS.
Full founder directory · Investor directory · Company funding database · Fundraising library